These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32495940)

  • 1. Probiotics and COVID-19: is there any link?
    Akour A
    Lett Appl Microbiol; 2020 Sep; 71(3):229-234. PubMed ID: 32495940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Probiotics in the Management of COVID-19: A Computational Perspective.
    Nguyen QV; Chong LC; Hor YY; Lew LC; Rather IA; Choi SB
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and Coronavirus disease 2019: think about the link.
    Angurana SK; Bansal A
    Br J Nutr; 2021 Nov; 126(10):1564-1570. PubMed ID: 32921328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
    Brahma S; Naik A; Lordan R
    Clin Nutr ESPEN; 2022 Oct; 51():17-27. PubMed ID: 36184201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiota-mediated dietary and nutritional interventions for COVID-19.
    Gasmi A; Tippairote T; Mujawdiya PK; Peana M; Menzel A; Dadar M; Benahmed AG; Bjørklund G
    Clin Immunol; 2021 May; 226():108725. PubMed ID: 33845194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm.
    Zeinali T; Faraji N; Joukar F; Khan Mirzaei M; Kafshdar Jalali H; Shenagari M; Mansour-Ghanaei F
    Microb Pathog; 2022 Sep; 170():105704. PubMed ID: 35948266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The volatile and heterogeneous gut microbiota shifts of COVID-19 patients over the course of a probiotics-assisted therapy.
    Wu C; Xu Q; Cao Z; Pan D; Zhu Y; Wang S; Liu D; Song Z; Jiang W; Ruan Y; Huang Y; Qin N; Lu H; Qin H
    Clin Transl Med; 2021 Dec; 11(12):e643. PubMed ID: 34962356
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective.
    Santacroce L; Inchingolo F; Topi S; Del Prete R; Di Cosola M; Charitos IA; Montagnani M
    Diabetes Metab Syndr; 2021; 15(1):295-301. PubMed ID: 33484986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics and Covid-19.
    Bottari B; Castellone V; Neviani E
    Int J Food Sci Nutr; 2021 May; 72(3):293-299. PubMed ID: 32787470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic supplementation: A prospective approach in the treatment of COVID-19.
    Nayebi A; Navashenaq JG; Soleimani D; Nachvak SM
    Nutr Health; 2022 Jun; 28(2):163-175. PubMed ID: 34747257
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of probiotics to combat viral infections with emphasis on COVID-19.
    Sundararaman A; Ray M; Ravindra PV; Halami PM
    Appl Microbiol Biotechnol; 2020 Oct; 104(19):8089-8104. PubMed ID: 32813065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Microbiota-A Promising Target for Antiviral Therapy?
    Yang M; Yang Y; He Q; Zhu P; Liu M; Xu J; Zhao M
    Front Immunol; 2021; 12():676232. PubMed ID: 34054866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges.
    Ailioaie LM; Litscher G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
    Barengolts E; Smith ED
    Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics Against Viruses; COVID-19 is a Paper Tiger: A Systematic Review.
    Paknahad Z; Moravejolahkami AR
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1252-1260. PubMed ID: 32940192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutraceuticals in the Prevention of Viral Infections, including COVID-19, among the Pediatric Population: A Review of the Literature.
    Parisi GF; Carota G; Castruccio Castracani C; Spampinato M; Manti S; Papale M; Di Rosa M; Barbagallo I; Leonardi S
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19, the Gut, and Nutritional Implications.
    Bell MG; Ganesh R; Bonnes SL
    Curr Nutr Rep; 2023 Jun; 12(2):263-269. PubMed ID: 36894741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecules Produced by Probiotics and Intestinal Microorganisms with Immunomodulatory Activity.
    Delgado S; Sánchez B; Margolles A; Ruas-Madiedo P; Ruiz L
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32024101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.